The fibroblast growth factor family and mood disorders

Novartis Foundation Symposium

Volumn 289, Issue , 2008, Pages 94-96

  Akil, H ^a   Evans, S J ^a   Turner, C A ^a   Perez, J ^a   Myers, R M ^b   Bunney, W E ^c   Jones, E G ^d   Watson, S J ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b STANFORD UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2;

ARTICLE; DEPRESSION; HUMAN; MOOD DISORDER; PATHOPHYSIOLOGY; PHYSIOLOGY;

DEPRESSION; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTORS; HUMANS; MOOD DISORDERS;

EID: 48849083248     PISSN: 15282511     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (4)

1. Evans SJ, Choudary PV, Neal CR et al 2004 Dysregulation of the fibroblast growth factor system in major depression. Proc Natl Acad Sci USA 101:15506-15511
2. Gaughran F, Payne J, Sedgwick PM, Cotter D, Berry M 2006 Hippocampal FGF-2 and FGFR1 mRNA expression in major depression, schizophrenia and bipolar disorder. Brain Res Bull 70:221-227
3. Maragnoli ME, Fumagalli F, Gennarelli M, Racagni G, Riva MA 2004 Fluoxetine and olanzapine have synergistic effects in the modulation of fibroblast growth factor 2 expression within the rat brain. Biol Psychiatry 55:1095-1102
4. Turner CA, Akil H, Watson SJ, Evans SJ 2006 The fibroblast growth factor system and mood disorders. Biol Psychiatry 59:1128-1135